Evidence map›Paper›PMID 38167302›Full record

Trial reportNature communications2024

Chronic oxytocin administration stimulates the oxytocinergic system in children with autism.

Matthijs Moerkerke, Nicky Daniels, Laura Tibermont, Tiffany Tang, Margaux Evenepoel, Stephanie Van der Donck, Edward Debbaut, Jellina Prinsen, Viktoria Chubar, Stephan Claes and 5 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06945926 (The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery:Two-Stage Designs for Phase II Clinical Trials), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06945926 phase2completednot on this mapstarted 2025, after this paper: background citation

The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery:Two-Stage Designs for Phase II Clinical Trials

TypeinterventionalSponsorZhejiang UniversityRan2025 to 2026Enrolled227ConditionsCervical Spinal Stenosis, Thoracic Spinal Stenosis, Lumbar Spinal Stenosis, Rotator Cuff InjuryArmsoxytocin nasal spray
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  18. Disorders of puberty and neurodevelopment: A shared etiology?Annals of the New York Academy of Sciences · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Matthijs Moerkerke *Center for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-7133-8418
Nicky Daniels *Leuven Autism Research (LAuRes), KU Leuven, Leuven, Belgium.ORCID 0000-0002-1104-0409
Laura TibermontCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Tiffany TangCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Margaux EvenepoelLeuven Autism Research (LAuRes), KU Leuven, Leuven, Belgium.ORCID 0000-0001-7050-8932
Stephanie Van der DonckCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Edward DebbautCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-3328-8560
Jellina PrinsenLeuven Autism Research (LAuRes), KU Leuven, Leuven, Belgium.ORCID 0000-0003-1994-7846
Viktoria ChubarUniversity Psychiatric Centre, KU Leuven, Leuven, Belgium.
Stephan ClaesUniversity Psychiatric Centre, KU Leuven, Leuven, Belgium.
Bart VanaudenaerdeLaboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Illness and Metabolism, KU Leuven, Leuven, Belgium.
Lynn WillemsLaboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Illness and Metabolism, KU Leuven, Leuven, Belgium.
Jean SteyaertCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Bart BoetsCenter for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-4718-667X
Kaat AlaertsLeuven Autism Research (LAuRes), KU Leuven, Leuven, Belgium. kaat.alaerts@kuleuven.be.ORCID 0000-0001-8665-6374
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical efficacy of intranasal administration of oxytocin is increasingly explored in autism spectrum disorder, but to date, the biological effects of chronic administration regimes on endogenous oxytocinergic function are largely unknown. Here exploratory biological assessments from a completed randomized, placebo-controlled trial showed that children with autism (n = 79, 16 females) receiving intranasal oxytocin for four weeks (12 IU, twice daily) displayed significantly higher salivary oxytocin levels 24 hours after the last oxytocin nasal spray administration, but no longer at a four-week follow up session. Regarding salivary oxytocin receptor gene (OXTR) epigenetics (DNA-methylation), oxytocin-induced reductions in OXTR DNA-methylation were observed, suggesting a facilitation of oxytocin receptor expression in the oxytocin compared to the placebo group. Notably, heightened oxytocin levels post-treatment were significantly associated with reduced OXTR DNA-methylation and improved feelings of secure attachment. These findings indicate that four weeks of chronic oxytocin administration stimulated the endogenous oxytocinergic system in children with autism.

Indexed as

Autism Spectrum DisorderAutistic DisorderAdministration, IntranasalChildDNAFemaleHumansOxytocinReceptors, OxytocinDNAOxytocinReceptors, Oxytocin

Identifiers

PMID38167302
PMCPMC10762037
OpenAlexW4390500224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.